Altamira Therapeutics Ltd. (CYTOF): 15-12G filed Feb 27, 2026

Form type

15-12G

Filing date

Feb 27, 2026

Accession number

0001213900-26-021580

Filer

Altamira Therapeutics Ltd. (CIK 1601936)